Exhibit 99.1
Form 51-102F3
Material Change Report
| Item 1 | Name and Address of Company |
Mind Medicine (MindMed) Inc. (the “Company”)
1166 Alberni Street, Suite 1604,
Vancouver, British Columbia
V6E 3Z
| Item 2 | Date of Material Change |
September 29, 2021
| Item 3 | News Release |
On September 30, 2021, a news release was disseminated through the newswire services of GlobalNewswire and subsequently filed on SEDAR at www.sedar.com.
| Item 4 | Summary of Material Change |
On September 29, 2021, the Company appointed Andreas Krebs and Carol Vallone as directors of the Company and Bruce Linton ceased to be a director of the Company.
| Item 5 | Full Description of Material Change |
| 5.1 | Full Description of Material Change |
On September 29, 2021, the Company appointed Andreas Krebs and Carol Vallone as directors of the Company and Bruce Linton ceased to be a director of the Company.
| 5.2 | Disclosure for Restructuring Transactions |
Not Applicable.
| Item 6 | Reliance on subsection 7.1(2) of National Instrument 51-102 |
Not Applicable.
| Item 7 | Omitted Information |
Not Applicable.
| Item 8 | Executive Officer |
For further information, please contact Rob Barrow, Chief Executive Officer of the Company, at 212-220-6633.
| Item 9 | Date of Report |
October 4, 2021.